)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Vetoquinol
Vetoquinol (VETO) investor relations material
Vetoquinol Q3 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 TU earnings summary28 Oct, 2026
Executive summary
Q3 sales reached €139.7m, up 10.4% reported and 9.6% at constant exchange rates, supported by Essentials growth and a favorable Q3 2025 base effect.
9M sales totaled €399.0m, up 3.9% reported and 5.4% at constant exchange rates; excluding product-line simplification, constant-currency growth was 6.6%.
Financial highlights
Q1 sales were €125.0m, down 4.3% reported and 0.3% at constant exchange rates; Q2 was €134.3m, up 5.7% and 7.2%, respectively.
Q3 sales were €139.7m, up 10.4% reported and 9.6% at constant exchange rates; favorable currency impact was €1m from the U.S. and Americas excluding the U.S.
9M reported sales growth was affected by a negative €6.1m currency impact and a €3.7m impact from product-line simplification.
Outlook and guidance
FY2026 annual sales release scheduled for January 14, 2027, after market close.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Vetoquinol
- Net income rose 22% to €30.5M, driven by U.S. and Essentials growth, with improved margins.VETO
H1 2026 - Q1 2026 sales nearly flat at constant exchange rates, with strong U.S. rebound amid currency headwinds.VETOQ1 2026 TU
- Essentials growth and improved profitability drive strong 2025 results despite currency headwinds.VETOH2 2025
- Essential Products drove growth to 64% of sales, offsetting currency and product range headwinds.VETOQ4 2025 TU
- Sales dipped 3.5% YTD, but Essential products grew to 64% of total sales.VETOQ3 2025 TU
- Essentials growth and higher margins offset sales decline, boosting profitability.VETOH1 2025
- Sales grew 1.8% YTD, with essential products now 61% of total sales.VETOQ3 2024 TU
- Sales up 3.2%, profit margins down as US sales softened and investment rose.VETOH1 2024
- Essentials drove 2.2% sales growth and profitability, offsetting U.S. decline.VETOH2 2024
Next Vetoquinol earnings date
Q4 2026 TU14 Jan, 2027
Vetoquinol
Next Vetoquinol earnings date
Q4 2026 TU14 Jan, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Vetoquinol SA is a French veterinary pharmaceutical company that focuses on the development, production, and marketing of veterinary drugs and non-medicinal products. The company provides a diverse range of products aimed at improving the health of companion animals, such as dogs and cats, as well as livestock including cattle and pigs. Vetoquinol's product offerings cover various therapy areas like pain management, mobility, inflammation, dermatology, udder health, anti-parasite solutions, and cardiology among others. The company is headquartered in Lure, France, and its shares are listed on the Euronext Paris.